Effect of Interleukin-1 Receptor Antagonist on Insulin Sensitivity in Obese, Insulin Resistant Individuals.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2011
At a glance
- Drugs Anakinra (Primary)
- Indications Insulin resistance
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 18 Dec 2009 Last checked against ClinicalTrials.gov record.
- 18 Dec 2009 Planned end date changed from 1 Jan 2010 to 1 Jul 2010 as reported by ClinicalTrials.gov